Company bodies

Management Board

Krzysztof
Kaczmarczyk

Chief Executive Officer

Krzysztof Kaczmarczyk

Chief Executive Officer

Manager with over 20 years of experience in investment banks and international corporations.
In 1999-2008 Krzysztof Kaczmarczyk worked for Deutsche Bank conducting market analyses in Central and Eastern Europe. In 2008-2010 he held management positions in Telekomunikacja Polska Group and Orange Group and was responsible for strategy and business development. In 2010-2011 he worked at Credit Suisse, a Swiss investment bank. From 2012 to 2015, he served as Vice President of the Supervisory Board for Strategy and Development at Emitel, an operator of terrestrial radio and television network in Poland. In 2016-2019 he served as Advisor to the Supervisory Board of KGHM Polska Miedź S.A. for Strategy and Development.
In parallel, he gained over 15 years of supervisory experience as member of supervisory boards of companies listed on the WSE. Since 2006 Krzysztof Kaczmarczyk has been a member of supervisory boards of more than 30 companies including: Action, Alta, Arteria, Braster, BEST, BSC Drukarnia, Celon Pharma, CI Games CP Energia, Develia, Duon, Emitel, Elektrotim, Enel Med, Enter Air, European Copper Institute, TP Edukacja i Wypoczynek, Warsaw Stock Exchange, Graal, Integer, InPost, Info-TV-Operator, KGHM Polska Miedź, KGHM International, KGHM TFI, Mabion, Magellan, Nextbike, Polimex-Mostostal, Polish Energy Partners, Robyg, RS TV, SARE, TIM, Vigo System, Wirtualna Polska, Work Service, 4fun Media.
Krzysztof Kaczmarczyk is a graduate of the Warsaw School of Economics (SGH) with a degree in Finance and Accounting. He also studied International Relations at the University of Warsaw.

Responsibilities
Krzysztof Kaczmarczyk, oversees the Board of Directors’ activities. The CEO’s primary responsibilities include creating the company’s investment policy and business plan as well as seeking out strategic partners. The CEO is also responsible for the areas of HR, legal, administration, investor relations and overseeing the correct execution of the Company’s business, scientific, operational and financial activities.

Julita
Balcerek, Ph.D, EMBA

Chief Operating Officer

Julita Balcerek, Ph.D, EMBA

Chief Operating Officer

Julita Balcerek, PhD, MBA, is a graduate of the University of Wroclaw in biotechnology. She earned her PhD in molecular and cellular biology by participating in the implementation doctorate program at the Medical University of Lodz. As part of her doctoral project, she developed an innovative platform to derive stable cell lines for the expression of recombinant proteins for biopharmaceutical applications. Julita Balcerek is also a graduate of the Polish-American MBA Program at the University of Lodz and is qualified as a certified IPMA-C Project Manager.
Julita Balcerek has been with Mabion S.A. since 2008, where she has built a team and its competencies in the development, manufacturing and control of biological medicinal products. During her career at Mabion S.A., she has served, among other things, as Project Manager of the “Transfer and Validation of the NVAX Protein Vaccine Manufacturing Process,” which ended successfully and resulted in a long-term collaboration with Novavax, Inc. for contract manufacturing of the SARS-CoV-2 vaccine antigen. For years, she has designed and actively supported the development of managerial competencies at the Company’s senior and middle management levels, including the Leadership Academy Program, which she designed and implemented in 2021.
Responsibilities
She is in charge of overseeing and coordinating the Company’s development, manufacturing, investment, and maintenance as well as qualification efforts. Responsible for creation and implementation of new process technologies and development of analytics characterizing biological products and processes. Oversees activities related to purchasing, warehousing, transportation and investment processes.

Grzegorz
Grabowicz

Chief Financial Officer

PhD Eng. Sławomir
Jaros, EMBA

Chief Scientific and Quality Affairs Officer

Adam
Pietruszkiewicz

Chief Commercial Officer

Adam Pietruszkiewicz

Chief Commercial Officer

Adam possesses extensive expertise in business development and a broad list of completed strategic projects in the region of Central and Eastern Europe.
He is a graduate of Boston University, where he majored in International Management and International Relations. Adam has over 20 years of experience in the private equity industry: he led the Polish operations of the Coast2Coast Capital fund, and before that, for over 13 years, he worked at The Riverside Company fund, where he also served as a Principal and headed the Polish office. While investing and developing companies from various industries (including healthcare, IT, industrial, FMCG) he built a network of strong contacts in the business environment in Poland and in the entire region of Central and Eastern Europe.

In his capacity as a Member of the Supervisory Board of Mabion S.A., Adam was twice delegated by the Supervisory Board to become a Member of the Management Board, for the first time from 17 September 2020 to 17 December 2020 and then from 25 January 2021 until the date of his resignation from the Supervisory Board due to his permanent appointment to the Management Board of the Company where he continues to serve as the Chief Commercial Officer.

Responsibilities
Within the Management Board, Adam is responsible for developing the Company’s business, acquiring new customers, building new industry relationships, and leading selected strategic projects related to the Company’s international expansion. He led the initiative to start the long-term cooperation with the company’s principal client, Novavax, Inc.

Supervisory Board

Graduate of the John F. Kennedy School of Government (MPA) at Harvard University and Tufts University (BA) in the United States. Since March 2020, he has been the President of the Supervisory Board and a Partner in the consulting company Five Rand Sp. z o.o. In recent years, he has worked for PGE Polska Grupa Energetyczna S.A., Kulczyk Holding S.A., Euronet Worldwide, Inc., and Horton International, among others. In 1990-1995, he served as advisor to the Minister of Finance (from Leszek Balcerowicz to Grzegorz Kołodko) on the transformation and restructuring of the Polish financial services sector; he was also a member of the team negotiating the agreement with the London Club. Currently, he serves on the Supervisory Board of Platige Image S.A. Robert Koński meets the independence criteria referred to in Rule II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

Robert Koński has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

Licensed Investment Advisor with license number 303 and holder of the CFA (Chartered Financial Analyst) title. Graduated from Warsaw School of Economics with a major in Finance and Banking, also studied at Aarhus School of Business in Denmark and Universität zu Köln in Germany, completed the Community of European Management Schools –Master’s in International Management (CEMS MIM) management program. Scholarship holder of the Educational Enterprise Foundation. He conducted classes on courses for stock brokers (ZMiD) and for investment advisors (PERK). He has over 10 years of experience in asset management. He has worked, among others, for the European Investment Fund in Luxembourg and the Morgan Stanley real estate fund in Frankfurt. In 2009-2020 he managed a number of different funds and investment strategies within TFI PZU, both with PZU Group’s own money and with money entrusted by external clients, equity, mixed and absolute return funds. The investment spectrum included companies listed on the WSE as well as those listed on stock exchanges in the EU and the USA. Member of the investment committee, AUM over PLN 20 billion. Since 2014 as a Medical Sector Director in TFI PZU he was responsible for investments in companies from the health care sector.

Sławomir Kościak meets the independence criteria referred to in principle II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

Graduate of the Faculty of Law of the Jagiellonian University in Kraków. Legal Counselor. Managing Partner at InCorpore Banach Szczypiński Partners. He started his career at the Ministry of Finance and then worked for PricewaterhouseCoopers sp. z o.o. for several years, most recently as the leader of the Proceedings and International Tax Law team. Member of a number of supervisory boards of capital companies, including, among others, Chairman of the Supervisory Board of Poczta Polska S.A. and PHN S.A. For many years an expert of the Tax Council of the Polish Confederation of Private Employers Lewiatan, including acting Head of the Tax Council. Author of numerous publications in the field of law, including the commentary “Polskie umowy o unikaniu podwójnego opodatkowania” [Polish agreements on avoiding double taxation] published by CH Beck. He repeatedly represented parties in proceedings before administrative authorities and administrative and common courts, which ended with the client’s success. Józef Banach meets the independence criteria referred to in principle II.Z.4 of the document “Code of Best Practice for WSE Listed Companies 2021”.

Józef Banach has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

Graduate of Cambridge University, Chartered Accountant with the Polish Chamber of Chartered Accountants and ICAEW (Institute of Chartered Accountants in England and Wales). Currently International Liaison Partner at Grupa Strategia, Poland. He has 28 years of experience in audit and internal control. Member of the supervisory boards of many companies and an advisor in the scope of establishing business in the region of Central and Eastern Europe for nearly fifty companies. Partner responsible for auditing financial statements of more than 100 companies and groups of companies from various business sectors, both listed companies, private equity funds and family businesses. He has conducted over 80 due diligence analyses, dealt with statutory, internal and forensic financial audits and provided business advisory services to a number of clients.

He has worked in Poland, UK, Germany, Czech Republic, Slovakia and Russia. He is fluent in eight languages and can communicate in twelve other. For four years, David James mentored about 100 teams of young entrepreneurs participating in the Cambridge Python Project. Within this project, organized under the aegis of the British Embassy and the University of Cambridge, David James trained students from all over Poland in creating modern business plans and budgeting. David James is the creator of an original method of learning foreign languages. He meets the independence criteria referred to in Rule II.Z.4 of the document “Best Practices of WSE Listed Companies 2021”.

David James has knowledge and skills in accounting / auditing.

Graduate of the Faculty of Medicine at the Medical University of Lodz and Postgraduate Studies in Management Accounting at the University of Lodz. Licensed securities broker (license No. 449). Associated with the capital market since 1994. Worked for HSBC Securities Polska, Dom Maklerski BZ WBK, Santander Biuro Maklerskie where he was responsible for sales to institutional clients (investment funds, pension funds, asset management companies). He is competent in conducting transactions on the domestic and foreign cash and derivatives markets. He participated in the preparation and conduct of numerous public offerings of companies on the primary and secondary market. Since July 2020 he has been working for Polfarmex S.A.

A graduate of ESCP-EAP Europe and the Poznań University of Economics with a degree in Finance and Accounting and a Master’s degree in Management. She has over 12 years of experience in the private equity industry, which she gained working in leading funds in Poland and abroad. Since 2016 she has been associated with the Polish Development Fund S.A., where she currently serves as Office Director in the Investment Department of PFR S.A. and President of the Supervisory Board of PFR Life Science Sp. z o.o., a company specializing in investments in the field of biotechnology and health. She gained previous experience in funds such as Mid Europa (2011-2015) and 3i (2009-2011). During this time, she had the opportunity to participate in numerous transactions in sectors such as new technologies, services, manufacturing, health and tourism.

Zofia Szewczuk has extensive ownership and supervisory experience, representing the investor side. Her input involves regular cooperation with the supervisory boards of companies in implementing development and remedial initiatives and monitoring their performance. Currently she is a member of the Supervisory Board of Polskie Kolei Linowe S.A. and an observer in HCP company. MsZofia Szewczuk meets the independence criteria referred to in principle 2.3 of the document “Code of Best Practice for WSE Listed Companies 2021”.

Zofia Szewczuk has knowledge of accounting and auditing and is skilled in the industry in which Mabion operates.

Committees

David John James Chairman of the Audit Committee
Józef Banach
Robert Koński
Sławomir Kościak
Zofia Szewczuk

Sławomir Kościak Chairman of the Appointment and Remuneration Committee
Robert Koński
David John James
Józef Banach
Wojciech Wośko